1 active not recruiting, 1 recruiting. .
Follow Fang Wu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC ctDNA detection - Advanced Lung Non-Small Cell Carcinoma | Active not recruiting | Fang Wu | 100 | 2022-01-24 | 2026-08-31 | |
| The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE) NO Intervention - The Efficacy and Safety of SBRT in MPLC | Recruiting | Fang Wu | 40 | 2021-07-01 | 2025-11-28 |
China (2)